An approach toHelicobacter pyloriinfection in the elderly
Authors:
- 3 April 2002
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 16 (4) , 683-691
Abstract
The prevalence ofHelicobacter pyloriinfection increases with age world‐wide, reaching levels of 40–60% in asymptomatic elderly subjects and over 70% in elderly patients with gastroduodenal diseases. However, the percentage ofH. pylori‐positive elderly patients who are treated for their infection remains very low.Data are now available that demonstrate the benefit of curingH. pyloriinfection in elderly patients withH. pylori‐associated peptic ulcer disease and severe chronic gastritis. Furthermore, the cure ofH. pylorimay prevent the progression of intestinal metaplasia and gastric atrophy. New studies are needed to clarify the role of eradication in elderly patients with non‐ulcer dyspepsia and gastro‐oesophageal reflux disease and in those who use non‐steroidal anti‐inflammatory drugs.H. pyloriinfection may be easily diagnosed by histological evaluation, rapid urease test or culture performed on gastric biopsies taken during endoscopy. However, the biopsy site must be carefully selected in elderly patients. For non‐invasive monitoring ofH. pyloriinfection after treatment, the13C‐urea breath test has significantly higher accuracy than serology in the elderly; further studies are needed to clarify the role of theH. pyloristool antigen test in old age.One‐week proton pump inhibitor‐based triple therapy regimens, including clarithromycin, amoxicillin and/or nitroimidazoles, are highly effective and well tolerated in elderly patients. Low doses of both proton pump inhibitors and clarithromycin (in combination with standard doses of amoxicillin or nitroimidazoles) are sufficient. Low compliance and antibiotic resistance are the main factors related to treatment failure in old age.Keywords
This publication has 65 references indexed in Scilit:
- Preventing Recurrent Upper Gastrointestinal Bleeding in Patients withHelicobacter pyloriInfection Who Are Taking Low-Dose Aspirin or NaproxenNew England Journal of Medicine, 2001
- Influence of age on the steady state disposition of drugs commonly used for the eradication of Helicobacter pyloriAlimentary Pharmacology & Therapeutics, 2000
- Upper gastrointestinal diseases in the elderlyEuropean Journal of Gastroenterology & Hepatology, 1999
- Evaluation of a new immunochromatographic test for Helicobacter pylori IgG antibodies in elderly symptomatic patientsJournal of Gastroenterology, 1999
- Role of Aging in the Expression of Helicobacter pylori Gastritis in the Antrum, Corpus, and CardiaScandinavian Journal of Gastroenterology, 1999
- Age and Helicobacter pylori decrease gastric mucosal surface hydrophobicity independentlyGut, 1998
- Cytotoxin-Associated Gene A-PositiveHelicobacter pylori Infection in the ElderlyJournal of Clinical Gastroenterology, 1998
- Atrophic Changes of Gastric Mucosa Are Caused by Helicobacter pylori Infection Rather Than Aging: Studies in Asymptomatic Japanese AdultsHelicobacter, 1996
- Prevalence of Helicobacter pylori Infection in Elderly Inpatients and in Institutionalized Old People: Correlation with Nutritional StatusAge and Ageing, 1996
- Therapeutic Effects of Lansoprazole on Peptic Ulcers in Elderly PatientsJournal of Clinical Gastroenterology, 1995